Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Medical Hypotheses|July 1, 1989
Epstein-Barr virus as a cause of autoimmune disease and other medical morbidity in patients with affective disordersR G Cooke, J J Warsh, G M HaseyThe Biochemical Journal|December 15, 1988
G-protein involvement in central-nervous-system muscarinic-receptor-coupled polyphosphoinositide hydrolysisA S Chiu, P P Li, J J WarshEuropean Journal of Pharmacology|August 29, 1980
Serotonin receptors in hippocampus and frontal cortexP Seeman, K Westman, D Coscina, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Metabolic fate of 3,4-dihydroxyphenylethyleneglycol (DHPG) in mouse brainP P Li, J J Warsh, D D GodseJournal of Neurochemistry|November 1, 1984
Formation and clearance of norepinephrine glycol metabolites in mouse brainP P Li, J J Warsh, D D GodseNeurochemical Research|August 1, 1988
In vitro and ex vivo effects of antidepressants on rat brain membrane-bound phosphatidylinositol synthetase activityP P Li, J J Warsh, N Z StanacevNeurochemistry International|May 28, 2010
Activation of phosphoinositide hydrolysis in rat cortical slices by guanine nucleotides and sodium fluorideP P Li, A S Chiu, J J WarshCanadian Journal of Physiology and Pharmacology|June 1, 1978
A radiotracer method for the measurement of central nervous system catecholamines in vivoS W Tang, H C Stancer, J J WarshJournal of Neurochemistry|July 1, 1992
Evidence for metabotropic excitatory amino acid receptor heterogeneity: developmental and brain regional studiesG G Vecil, P P Li, J J WarshNaunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1986
Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formationP P Li, J J Warsh, D D GodsePageof 10